Cosmos Health Inc.
Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, Croatia, Bulgaria, the United Arab Emirates, the United Kingdom, and Cyprus. The company offers prescription medications, over-the-counter drugs, medical devices, food supplements, nutraceuticals, cosmetics and other healthcare products under the Sky Premium Life and Mediterranation brand names. It als… Read more
Cosmos Health Inc. (COSM) - Total Liabilities
Latest total liabilities as of September 2025: $46.36 Million USD
Based on the latest financial reports, Cosmos Health Inc. (COSM) has total liabilities worth $46.36 Million USD as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Cosmos Health Inc. - Total Liabilities Trend (2009–2024)
This chart illustrates how Cosmos Health Inc.'s total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Cosmos Health Inc. Competitors by Total Liabilities
The table below lists competitors of Cosmos Health Inc. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
artnet AG
PINK:ARTZF
|
USA | $10.17 Million |
|
JCBNext Berhad Bhd
KLSE:0058
|
Malaysia | RM7.57 Million |
|
Chromocell Therapeutics Corporation
NYSE MKT:CHRO
|
USA | $7.32 Million |
|
Taiwan Advanced Nanotech Inc.
TWO:6797
|
Taiwan | NT$450.26 Million |
|
FORIS AG
F:FRS
|
Germany | €3.31 Million |
|
NFL Biosciences SAS
PA:ALNFL
|
France | €2.60 Million |
Liability Composition Analysis (2009–2024)
This chart breaks down Cosmos Health Inc.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.99 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 2.00 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.67 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Cosmos Health Inc.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Cosmos Health Inc. (2009–2024)
The table below shows the annual total liabilities of Cosmos Health Inc. from 2009 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $29.78 Million | -0.64% |
| 2023-12-31 | $29.97 Million | +5.60% |
| 2022-12-31 | $28.38 Million | -37.00% |
| 2021-12-31 | $45.05 Million | -6.16% |
| 2020-12-31 | $48.01 Million | +58.22% |
| 2019-12-31 | $30.34 Million | +26.35% |
| 2018-12-31 | $24.01 Million | +75.23% |
| 2017-12-31 | $13.70 Million | +181.31% |
| 2016-12-31 | $4.87 Million | +155.66% |
| 2015-12-31 | $1.91 Million | +8.20% |
| 2014-12-31 | $1.76 Million | +91.25% |
| 2013-12-31 | $920.73K | +65526.09% |
| 2012-12-31 | $1.40K | -92.99% |
| 2011-12-31 | $20.00K | +11.41% |
| 2010-12-31 | $17.95K | +290.24% |
| 2009-12-31 | $4.60K | -- |